REPL

Conviction 82HealthcareScan · Thu, Sep 24, 2026

Hammer

Replimune Group, Inc. (REPL) closed at $12.59 (-2.89%) on Sep 24, 2026. Its latest daily candle is a hammer. Price is below its 50-day and above its 200-day moving average. RSI(14) 41, RS Rating 99, -21.3% from its 52-week high, +41.4% year to date. Sector: Healthcare · BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES).

REPL$12.59-2.89%

ResistanceSupportVol 14Insider buyInsider sell

Vol MA14 2.27M

Jun 25Jul 14Aug 3Aug 19Sep 8Sep 24

Replimune Group, Inc.BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)www.replimune.com ↗

Price12.59

Change-2.89%

Gap-1.08%

Rel volume3.00×

Avg volume2.13M

Avg $ vol29.33M

SMA 2014.03

SMA 5012.93

SMA 2008.85

Price vs 50-2.69%

Price vs 200+42.18%

MA stackmixed

50/200 cross—

Supertrenddown · 14.91

RSI (14)41

MACD hist-0.24

MACD cross—

Stoch %K / %D16 / 19

ADX (14)19

+DI / −DI19 / 26

RSI divergenceBearish

MACD divergenceBearish

ATR %6.98%

ADR %5.24%

52w high15.98

52w low1.70

From 52w high-21.25%

Above 52w low+640.29%

New 52w highNo

SqueezeOff

Bollinger width33.77%

%B0.19

Donchian pos12.09%

Donchian high16.33

Donchian low12.07

AVWAP (52w high)13.44

vs AVWAP high-6.33%

AVWAP (52w low)7.30

vs AVWAP low+72.45%

OBV trendDown

Chaikin MF (20)-0.06

Today vs 20d3.00×

Avg vol (14d)2.27M

Avg vol (20d)2.13M

Avg $ vol (20d)29.33M

Market cap1.19B

RS Rating99 / 99

RS 3m (vs SPY)+7.03%

RS 6m (vs SPY)+63.09%

RS line new highNo

Trend template7/8

Technical rank68.9

1 week-2.21%

1 month-20.35%

3 months+11.67%

6 months+80.56%

1 year+284.86%

YTD+41.40%

P/E-3.78

P/B11.22

P/S—

P/FCF-4.20

EPS-3.38

Div yield—

ROE-297.16%

ROA-124.36%

Debt/Eq0.80

Current5.23

EV/EBITDA-3.43

Gross margin—

Net margin—

Rev growth—

EPS growth-26.95%

Price target19.14

Target upside52.09%

Analyst ratingBuy

Institutional105.34%

Ent. value1.08B

Revenue0

Net income-69.77M

Gross profit—

Free cash flow-282.61M

IndustryBIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)

ExchangeNasdaq

Shares out82.57M

Employees479

ListedFri, Jul 20, 2018

Free float62.65M

Float %75.9%

Short interest23.52M

Days to cover8.9d

Short volume75.1%

Squeeze score100 / 100

Next earnings—

EPS forecast—

Last EPS vs est−$0.72 vs −$0.72

Last surprise0.0% beat

Setup gradeA

Conviction82 / 100

Pattern quality—

Tech rank68.9 / 100

Group rank59 / 100

Status lane—

Setup direction—

Pattern family

Resistance—

Support—

Days since event—

Candle confirmHammer

Financials as of Tue, Jun 30, 2026 · quarterly.

Congress activity

Disclosed STOCK Act trades in REPL

All disclosures →

No recent disclosed trades by Congress in REPL. STOCK Act filings can lag the trade by up to 45 days.

Insider activity

SEC Form 4 transactions in REPL · open-market 2 buys · 7 sells

Insider	Side	Shares	Value	Traded	Filed
Astley-Sparke Philip Director · Common Stock · 2026-08-20	Gift	50K	—	2026-08-20	2026-08-24
Hill Emily Luisa Chief Financial Officer · Common Stock · 2026-08-17	Sell	9.26K	$132K	2026-08-17	2026-08-19
Hill Emily Luisa Chief Financial Officer · Common Stock · 2026-08-10	Sell	11.45K	$148K	2026-08-10	2026-08-12
Patel Sushil Chief Executive Officer · Common Stock · 2026-08-10	Sell	39.34K	$510K	2026-08-10	2026-08-12
Schwendenman Andrew Chief Accounting Officer · Common Stock · 2026-08-10	Sell	7.63K	$99K	2026-08-10	2026-08-12
Xynos Konstantinos Chief Medical Officer · Common Stock · 2026-08-10	Sell	11.45K	$148K	2026-08-10	2026-08-12
BAKER BROS. ADVISORS LP Director · 2026 $0.0001 Prefunded Warrants · 2026-08-11	Buy	126.39K	$1.5M	2026-08-11	2026-08-11
BAKER BROS. ADVISORS LP Director · 2026 $0.0001 Prefunded Warrants · 2026-08-11	Buy	2.61M	$31M	2026-08-11	2026-08-11
Sarchi Christopher Chief Commercial Officer · Common Stock · 2026-06-01	Sell	12K	$111K	2026-06-01	2026-06-03
Xynos Konstantinos Chief Medical Officer · Common Stock · 2026-05-18	Sell	14.02K	$71K	2026-05-18	2026-05-20

SEC filings

EDGAR filings in REPL · 10 recent

EDGAR →

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 14 days, cancel in one click.

Start free — 14-day full access →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.